Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.51B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.04B |
| 4 |
American Express
AXP
|
+$714M |
| 5 |
HCA Healthcare
HCA
|
+$675M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$6.87B |
| 2 |
Wells Fargo
WFC
|
+$6.1B |
| 3 |
Becton Dickinson
BDX
|
+$3.96B |
| 4 |
Tesla
TSLA
|
+$3.74B |
| 5 |
3M
MMM
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 15.4% |
| 3 | Healthcare | 15.27% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Communication Services | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Thermo Fisher Scientific
TMO
$213B
| $1.59B | 0.18% |
6,499,139
+1,016,082
| +19% | +$234M |
|
102
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $1.57B | 0.18% |
5,417,471
+6,731
| +0.1% | +$1.92M |
|
103
General Dynamics
GD
$104B
| $1.57B | 0.18% |
7,674,090
-50,839
| -0.7% | -$9.95M |
|
104
Synchrony
SYF
$24.7B
| $1.56B | 0.18% |
50,346,639
+563,203
| +1% | +$17.9M |
|
105
Marriott International
MAR
$98.3B
| $1.55B | 0.17% |
11,750,984
-3,290,019
| -22% | -$420M |
|
106
Biogen
BIIB
$30B
| $1.53B | 0.17% |
4,322,187
-1,025,928
| -19% | -$353M |
|
107
Morgan Stanley
MS
$331B
| $1.52B | 0.17% |
32,690,082
-13,126,956
| -29% | -$641M |
|
|
108
HCA Healthcare
HCA
$87.2B
| $1.52B | 0.17% |
10,907,407
+5,419,134
| +99% | +$675M |
|
109
American International
AIG
$41.7B
| $1.51B | 0.17% |
28,305,780
+5,684,245
| +25% | +$305M |
|
110
CSX Corp
CSX
$93.4B
| $1.5B | 0.17% |
60,881,616
-4,646,484
| -7% | -$111M |
|
111
Travelers Companies
TRV
$78.1B
| $1.5B | 0.17% |
11,564,286
-367,277
| -3% | -$47.4M |
|
112
British American Tobacco
BTI
$131B
| $1.5B | 0.17% |
32,095,177
-671,488
| -2% | -$34.1M |
|
113
Norfolk Southern
NSC
$75.4B
| $1.46B | 0.16% |
8,080,231
+1,043,444
| +15% | +$178M |
|
114
Nektar Therapeutics
NKTR
$2.39B
| $1.46B | 0.16% |
1,594,638
-119,089
| -7% | -$102M |
|
115
Philip Morris
PM
$297B
| $1.45B | 0.16% |
17,774,120
-1,074,200
| -6% | -$88.2M |
|
|
PPL
116
PPL Corp
PPL
$26.5B
| $1.43B | 0.16% |
48,751,387
+1,474,816
| +3% | +$43.1M |
|
117
MSCI
MSCI
$41.6B
| $1.42B | 0.16% |
8,032,189
-682,676
| -8% | -$119M |
|
118
iShares Core S&P Small-Cap ETF
IJR
$109B
| $1.42B | 0.16% |
16,319,260
-238,752
| -1% | -$20.9M |
|
119
Gilead Sciences
GILD
$162B
| $1.41B | 0.16% |
18,210,622
-1,376,432
| -7% | -$104M |
|
120
AT&T
T
$159B
| $1.41B | 0.16% |
55,417,296
-3,470,007
| -6% | -$85M |
|
121
AstraZeneca
AZN
$263B
| $1.4B | 0.16% |
17,662,895
+7,541,304
| +75% | +$570M |
|
122
Nike
NKE
$61.9B
| $1.4B | 0.16% |
16,479,696
+818,695
| +5% | +$65.8M |
|
123
T-Mobile US
TMUS
$185B
| $1.38B | 0.16% |
19,644,093
+462,053
| +2% | +$29.7M |
|
124
PTC
PTC
$15.8B
| $1.38B | 0.16% |
12,970,601
-1,384
| -0% | -$135K |
|
|
RTN
125
DELISTED
Raytheon Company
RTN
| $1.37B | 0.15% |
6,626,729
-1,615,601
| -20% | -$322M |
|
Similar funds
Fidelity Investments's Q3 2018 Portfolio in Review
As of Q3 2018, Fidelity Investments held 3,957 positions worth $889B, up 2.3% from $869B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Fidelity Investments withdrew a net $33.9B in Q3 2018, closing 54 positions and reducing 1,318 holdings. Its most notable exit was Williams Partners L.P., an estimated $511M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Fidelity Investments opened a new position in Rubius Therapeutics, Inc worth $141M.
- Fidelity Investments's largest Q3 2018 buy was Rubius Therapeutics, Inc: 6,226,764 shares worth $141M.
- Fidelity Investments added most to Apple in Q3 2018, an estimated $1.51B increase.
- Fidelity Investments's biggest Q3 2018 reduction was Amgen, cutting an estimated $6.87B.
- Fidelity Investments fully exited Williams Partners L.P. in Q3 2018, selling an estimated $511M.
- Fidelity Investments's ten largest holdings make up 22% of its $889B portfolio in Q3 2018.
- Fidelity Investments opened 1,284 new positions and closed 54 in Q3 2018.
- Fidelity Investments's portfolio value rose 2.3% quarter-over-quarter to $889B.
Based on Fidelity Investments's 13F filing for Q3 2018, filed 9 Nov 2018.